Formulary
Bismuth subcitrate potassium with metronidazole and tetracycline hydrochloride: Indications, Dosing, Side Effects and Interactions
Bismuth subcitrate potassium with metronidazole and tetracycline hydrochloride clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Bismuth subcitrate potassium with metronidazole and tetracycline hydrochloride: Indications, Dosing, Side Effects and Interactions
Bismuth subcitrate potassium with metronidazole and tetracycline hydrochloride clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Helicobacter pylorieradication [doses**
- **Adult** (By Mouth): Helicobacter pylori eradication [doses for 140/125/125 mg capsules in combination with omeprazole], Prevention of relapse of Helicobacter pylori -associated peptic ulcers [doses for 140/125/125 mg capsules in combination with omeprazole] 3 capsules 4 times a day for 10 days.
Cautions
For bismuth subcitrate potassium with metronidazole and tetracycline hydrochloride Gastro-intestinal tract x-ray (bismuth absorbs x-rays and may interfere with such diagnostic procedures); low-potassium diet ( Pylera is high in potassium)
Side effects
For bismuth subcitrate potassium with metronidazole and tetracycline hydrochloride Common or very common Appetite decreased; asthenic conditions; constipation; diarrhoea; dizziness; drowsiness; dry mouth; gastrointestinal discomfort; gastrointestinal disorders; headache; increased risk of infection; nausea; skin reactions; taste altered; urine discolouration; vomiting Uncommon Anxiety; burping; chest discomfort; depression; insomnia; memory loss; oral disorders; sensation abnormal; tongue discolouration; tremor; vertigo; vision blurred Frequency not known Encephalopathy; meningitis aseptic; peripheral neuropathy; pseudomembranous enterocolitis; severe cutaneous adverse reactions (SCARs)
Pregnancy
For bismuth subcitrate potassium with metronidazole and tetracycline hydrochloride Avoid (no information available). M
Breast feeding
For bismuth subcitrate potassium with metronidazole and tetracycline hydrochloride Avoid (presence of bismuth subcitrate potassium in milk unknown). M
Hepatic impairment
For bismuth subcitrate potassium with metronidazole and tetracycline hydrochloride Avoid (no information available). M
Renal impairment
For bismuth subcitrate potassium with metronidazole and tetracycline hydrochloride Avoid (no information available). M
Medicinal forms
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Bismuth subcitrate potassium with metronidazole and tetracycline hydrochloride in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

